CCLG Special Named Funds fund new leukaemia research through partnership with VIVO Biobank
New research into acute myeloid leukaemia (AML) has been funded, thanks to two Children’s Cancer and Leukaemia Group (CCLG) Special Named Funds.
New research tool gives insights into the origins of childhood neuroblastoma
Research projects funded through the CCLG Research Funding Network have contributed to a new tool for neuroblastoma research.
CCLG teams up with VIVO Biobank to fund exciting new research
Children’s Cancer and Leukaemia Group (CCLG) has funded four new research projects as part of a brand-new initiative that will help provide researchers in the early stages of their career with vital experience.
CCLG Research Talks: What is cancer care like for teenagers and young adults?
Jo Stark tells us about young people's cancer care in a special Teenage and Young Adult Cancer Awareness Month webinar.
CCLG Research Talks: What can patients' blood tell us about Wilms tumour?
Hear from Professor Matthew Murray about Wilms tumour and improving kidney cancer care.
The Little Princess Trust has funded exciting new projects through CCLG
The Little Princess Trust (LPT) has announced 10 new research projects that will improve outcomes for children with cancer, awarded in partnership with Children’s Cancer and Leukaemia Group (CCLG).
CCLG Research Talks: How can leukaemia treatment affect a child's brain?
Professor Chris Halsey tells us about leukaemia treatment and how it can affect the brain.
New research into rare and unusual cancer funded, thanks to CCLG Special Named Funds
Children's Cancer and Leukaemia Group (CCLG) is proud to announce its first research project into Langerhans cell histiocytosis (LCH), a rare type of cancer that affects just 50 children per year in the UK.
TYAC researcher brings together young people who have had skin cancer and professionals at special event
Dr Wendy McInally, who leads Teenagers and Young Adults with Cancer (TYAC)’s first research project, hosted an event last month at the Royal College of Nursing which brought together survivors, clinical specialists and key stakeholders with experience of melanoma to inform the next steps of her research.